Event Details


Reserve your stay at the Glenpool now for special pricing!

Tandy Conference Center Buprenorphine Waiver Training
Tandy Conference Center Buprenorphine Waiver Training

Date: Nov 22, 2019

Location: 1111 West 17th Street Tulsa, OK 74107

Graduate Medical Education on Treatment of Opioid Use Disorders Project

About this Event

Distinguished Speakers

Ray Denny, D.O.

Assistant Clinical Professor

Division of Addiction Medicine

Department of Psychiatry and Behavioral Sciences

OSU Center for Health Sciences

Kelly Dunn, M.D.

Assistant Clinical Professor of Psychiatry

Division of Addiction Medicine

Medical Director of Student & Resident Wellness

OSU Center for Health Sciences

“OSU Medicine is committed to expanding access to treatment for Oklahomans who suffer from opioid use disorders through physician training. As a land-grant university, we are here to serve our fellow Oklahomans in their time of need.” – Dr. Kayse Shrum, President, OSU Center for Health Sciences.

The purpose of this is to better prepare physicians and medical students to identify individuals with opioid use disorders and to engage those patients in medication-assisted treatment for their opioid use disorder.

The course will be a total of 8 hours of in-person lecture, which will cover all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine.

Location and Lunch

Room #421

Lunch is not provided. A one-hour lunch break is planned to allow participants to dine off campus or order food for delivery to the building. Personal snacks and beverages are welcome in the event room.

The OSU-COM Continuing Medical Education office designates this program for a maximum of 8 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081663-1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

The American Academy of Addiction Psychiatry is approved by the Drug Abuse Treatment Act of 2000 (DATA) to provide the required eight-hour training that qualifies physicians for the waiver to prescribe Buprenorphine for treating opioid use disorders. AAAP is the Data Sponsor for this event.

Date And Time

Fri, November 22, 2019

8:00 AM – 5:00 PM CST


Tandy Conference Center, Room #421

1111 West 17th Street

Tulsa, OK 74107

United States

View All Events